Transforming Urologic Care in Philadelphia and Worldwide. The Fox Chase – Temple Urologic Institute. - Scorecard - MDSpire

Transforming Urologic Care in Philadelphia and Worldwide. The Fox Chase – Temple Urologic Institute.

  • By

  • May 21, 2026

  • 3 min

Share

Clinical Scorecard: Transforming Urologic Care in Philadelphia and Worldwide. The Fox Chase – Temple Urologic Institute

At a Glance

CategoryDetail
Condition
Key MechanismsSurgical options including robotics, focal therapy, and complex open procedures; advanced diagnostic panels for tumor evaluations.
Target Population
Care Setting

Key Highlights

  • Globally recognized for expertise in kidney cancer, bladder cancer, and interstitial cystitis.
  • One of the largest bladder preservation programs in the country.
  • Innovative clinical trials including RETAIN and INSITE.
  • Elite residency and fellowship programs training future leaders in urology.
  • Inventor of the R.E.N.A.L Nephrometry score for renal mass categorization.

Guideline-Based Recommendations

Diagnosis

  • Utilization of systematic endoscopic evaluation and blood/urine-based assays for tumor detection.

Management

  • Comparison of gemcitabine addition to BCG therapy for recurrent NMIBC.

Monitoring & Follow-up

  • Adaptive radiation therapy safety assessments for prostate cancer.

Risks

  • Potential risks associated with advanced surgical and therapeutic interventions.

Patient & Prescribing Data

Patients undergoing treatment for urologic cancers and conditions.

Access to advanced treatments and novel clinical trials.

Clinical Best Practices

  • Integration of urologic oncology and radiation oncology for comprehensive care.
  • Use of predictive nomograms for assessing cancer recurrence risk.

Related Resources & Content

Original Source(s)

Related Content